LINDSEY KLINGES: Open Payments
NPI 1679333421 · EDWARDSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 88 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $729 · 2025 $1,902
Food & beverage: $1,803Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $327 |
| Janssen Biotech, Inc. | 18 | $314 |
| Ardelyx, Inc. | 8 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $204 |
| Phathom Pharmaceuticals, Inc. | 6 | $195 |
| Madrigal Pharmaceuticals | 7 | $136 |
| Aimmune Therapeutics, Inc. | 6 | $97 |
| Ferring Pharmaceuticals Inc. | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
Products named: TREMFYA, IBSRELA, XIFAXAN, VOQUEZNA, RINVOQ, REZDIFFRA, CREON, ENTYVIO.
Industry payments across PA — which companies pay providers there.
